Storia in 5 fonti

As US measles cases rise, biotech firms start developing new treatments

The US is making measles great again, so treatment options are needed for the most vulnerable.

Raccontata da

Confronto fonti

5 prospettive sulla stessa storia

AI · summaries

arstechnica.comStai leggendo7 g fa

As US measles cases rise, biotech firms start developing new treatments

The US is making measles great again, so treatment options are needed for the most vulnerable.

originale

Timeline cronologica

wired.com

8 g fa

Measles Is Becoming So Common That Treatments May Soon Be Needed

As the US sees its highest number of measles cases in decades and vaccination rates fall, researchers are developing drugs to help those who contract the virus or who are particularly vulnerable.

Leggi questa versione → originale

forbes.com6 g fa

The Return of Measles In The U.S. Is Costing Every Taxpayer

The U.S. is on the verge of losing its measles elimination status for the first time in 25 years. Oubreaks are a hidden tax, leading to higher costs and economic losses.

Leggi questa versione → originale

dw.com8 g fa

'Amnesia' about measles risk pushes growth in US infections

The latest US data shows measles cases up to mid-July 2026 totaled more than all the cases in 2025. Experts blame a fall in vaccination and warn people have forgotten measles can be life-threatening.

Leggi questa versione → originale

time.com7 g fa

Measles Cases in the U.S. Are at a 35-Year High

New numbers from the CDC reveal a trend that's worrying experts.

Leggi questa versione → originale

lunedì 27 luglio 2026·

time.com

Measles Cases in the U.S. Are at a 35-Year High

New numbers from the CDC reveal a trend that's worrying experts.

martedì 28 luglio 2026·

arstechnica.com

As US measles cases rise, biotech firms start developing new treatments

The US is making measles great again, so treatment options are needed for the most vulnerable.

mercoledì 29 luglio 2026·

forbes.com

The Return of Measles In The U.S. Is Costing Every Taxpayer

The U.S. is on the verge of losing its measles elimination status for the first time in 25 years. Oubreaks are a hidden tax, leading to higher costs and economic losses.